I am not across nutraceuticals markets i am sorry - I know...

I am not across nutraceuticals markets i am sorry - I know Blackmores is a 8BN mkt cap !!! placebo company so must be some upside in this space ??

For me:

The key issues with MDC are simple - product is TGA approved and ready for sale, export is allowed, with TGA stamp and research coming from RNS trial, sales estimate for Nanbis in Aus alone or 130,000 patients.

we must be clear - product is approved and ready for sale under SAS - there are about 52 current patients approved to use or something stupid like that, but that figure will change dramatically in next year - especially as Dr's become approved and work out there is a dollar in it. The new single approval process will help solve for this.

but the big prize is TGA approved/Research supported exports to US - first into legal states but the prospect of FDA backing if Sessions is forced to deal with facts on opioid replacement - that is when things get really interesting

bookmark these comments / keep us all honest